RemeGen Co. Ltd. Class A
688331
Hisse Senetlerindeki Sıralama
#2418
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Hisse Fiyatı
$14.49
Piyasa Değeri
$8.11B
Değişim (1 gün)
2.99%
Değişim (1 yıl)
9.18%
Ülke
CN
Ticaret RemeGen Co. Ltd. Class A (688331)
Kategori
Healthcare
RemeGen Co. Ltd. Class A (688331) için P/S oranı
October 2026 itibarıyla P/S oranı TTM: 6.90
RemeGen Co. Ltd. Class A şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 6.90'dir. 2023 yılının sonunda şirketin P/S oranı 30.40 idi.
RemeGen Co. Ltd. Class A için P/S oranı geçmişi 2018 - 2026 arası
Her yılın sonunda P/S oranı
| Yıl | P/S Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 6.90 | -26.70% |
| 2024 | 9.42 | -68.99% |
| 2023 | 30.40 | -42.87% |
| 2022 | 53.20 | 280.55% |
| 2021 | 13.98 | -100.04% |
| 2020 | -34.32K | 0.00% |
| 2019 | 0.00 | -100.00% |
| 2018 | 1.73K | 0.00% |
Benzer şirketler veya rakipler için P/S oranı
| Şirket | P/S Oranı | P/S Oranı Farkı | Ülke |
|---|---|---|---|
| 10.02 | 45.16% |
US
|
|
| 40.55 | 487.32% |
US
|
|
| 3.96 | -42.63% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 46.95% |
NL
|
